Estefanía
Pérez Lopez
Ikertzailea 2016-(e)tik
MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
MARÍA DOLORES CABALLERO BARRIGÓN-rekin lankidetzan egindako argitalpenak (2)
2017
-
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 1, pp. 53-59
2014
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690